Study Onethird of pancreatic cancer patients miss out on treatment that may extend survival

Study: One-third of pancreatic cancer patients miss out on treatment that may extend survival

Despite potential for prolonging survival with treatment, one-third of patients with metastatic pancreatic cancer do not see a medical oncologist, and even more do not receive cancer-directed treatment, found new research published in CMAJ.

More From BioPortfolio on "Study: One-third of pancreatic cancer patients miss out on treatment that may extend survival"